{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:23:45Z","timestamp":1792038225731,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013006","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000}}],"reference-count":104,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013006.pub2","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T13:48:15Z","timestamp":1595252895000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Interventions for the management of obesity in people with bipolar disorder"],"prefix":"10.1002","volume":"2020","author":[{"given":"Agnes","family":"Tully","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Smyth","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Conway","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Geddes","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"Devane","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Kelly","sequence":"additional","affiliation":[{"name":"Pharmacology and Therapeutics; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fionnuala","family":"Jordan","sequence":"additional","affiliation":[{"name":"School of Nursing and Midwifery; National University of Ireland Galway; Galway Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD013006.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.4088\/JCP.v67n0812","article-title":"Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial","volume":"67","author":"Alvarez-Jim\u00e9nez","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1-3","key":"10.1002\/14651858.CD013006.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.schres.2007.03.029","article-title":"Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial","volume":"93","author":"Baptista","year":"2007","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD013006.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1176\/appi.ajp.2014.14030357","article-title":"Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes","volume":"172","author":"Bartels","year":"2015","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013006.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/104012371102300306","article-title":"Effects of orally disintegrating vs regular olanzapine tablets on body weight, eating behavior, glycemic and lipid indices, and gastrointestinal hormones: a randomized, open comparison in outpatients with bipolar depression","volume":"23","author":"Bobo","year":"2011","journal-title":"Annals of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0005|cit5","first-page":"5","article-title":"Zonisamide for bipolar disorder, mania or mixed states: a randomized, double blind, placebo-controlled adjunctive trial","volume":"44","author":"Dauphinais","year":"2011","journal-title":"Psychopharmacology Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.euroneuro.2004.03.005","article-title":"Amantadine for weight gain associated with olanzapine treatment","volume":"15","author":"Deberdt","year":"2005","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD013006.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2147\/TCRM.S3153","article-title":"Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder","volume":"4","author":"Deberdt","year":"2008","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD013006.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1399-5618.2006.00345.x","article-title":"Carnitine does not improve weight loss outcomes in valproate-treated bipolar patients consuming an energy-restricted, low-fat diet","volume":"8","author":"Elmslie","year":"2006","journal-title":"Bipolar Disorders"},{"issue":"2","key":"10.1002\/14651858.CD013006.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.4088\/JCP.14m09552","article-title":"Behavioral interventions for antipsychotic medication-associated obesity: a randomized, controlled clinical trial","volume":"77","author":"Erickson","year":"2016","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD013006.pub2-BIB0010|cit10","first-page":"479","article-title":"Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial","volume":"39","author":"Evans","year":"2005","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013006.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/bdi.12283","article-title":"An integrated risk reduction Intervention can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial","volume":"17","author":"Frank","year":"2015","journal-title":"Bipolar Disorders"},{"issue":"5","key":"10.1002\/14651858.CD013006.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"pii:PCC09m00906","DOI":"10.4088\/PCC.09m00906yel","article-title":"Effects of a multimodal lifestyle intervention on body mass index in patients with bipolar disorder: a randomized controlled trial","volume":"12","author":"Gillhoff","year":"2010","journal-title":"Primary Care Companion to the Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0013|cit13","unstructured":"Effects of a lifestyle intervention on body mass index in patients with bipolar disorder clinicaltrials.gov\/show\/NCT00980863"},{"issue":"8","key":"10.1002\/14651858.CD013006.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1176\/appi.ps.201200314","article-title":"\"MOVE!\" Outcomes of a weight loss program modified for veterans with serious mental illness","volume":"64","author":"Goldberg","year":"2013","journal-title":"Psychiatric Services"},{"issue":"9","key":"10.1002\/14651858.CD013006.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1176\/appi.ajp.162.9.1744","article-title":"DO double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine","volume":"162","author":"Graham","year":"2005","journal-title":"American Journal of Psychiatry"},{"issue":"30","key":"10.1002\/14651858.CD013006.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"10577","DOI":"10.3748\/wjg.v20.i30.10577","article-title":"Aerobic exercise improves gastrointestinal motility in psychiatric inpatients","volume":"20","author":"Kim","year":"2014","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD013006.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1399-5618.2007.00488.x","article-title":"A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders","volume":"9","author":"McElroy","year":"2007","journal-title":"Bipolar Disorders"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02850000","article-title":"Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study","volume":"24","author":"Milano","year":"2007","journal-title":"Advances in Therapy"},{"issue":"5","key":"10.1002\/14651858.CD013006.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/cap.2016.0046","article-title":"Melatonin for reducing weight gain following administration of atypical antipsychotic olanzapine for adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled trial","volume":"27","author":"Mostafavi","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0020|cit20","unstructured":"The assessment of sibutramine for the treatment of olanzapine-associated weight gain in subjects with schizophrenia, schizophreniform disorder, schizoaffective disorder, and bipolar I disorder (StudyF1D-MC-HGJJ, Summary ID# 5102 https:\/\/benmeg.com\/archives\/rxarchives.org\/olanzapine%20(Zyprexa)\/5102_online.pdf (accessed 18 June 2020) 2006"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0021|cit21","unstructured":"The assessment of an anti-obesity agent for the treatment of olanzapine-associated weight gain in patients with schizophrenia, schizophreniform disorder, schizoaffective disorder and bipolar I disorder clinicaltrials.gov\/ct2\/show\/NCT00044187"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0022|cit22","unstructured":"Comparing the effect of under the tongue olanzapine versus swallowed olanzapine on body mass index (a ratio of weight to height) clinicaltrials.gov\/show\/NCT00303602"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0023|cit23","unstructured":"Geodon in weight loss study for bipolar disorders clinicaltrials.gov\/show\/NCT00472641"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0024|cit24","unstructured":"Exenatide for the treatment of weight gain associated with olanzapine in obese adults clinicaltrials.gov\/show\/NCT00845507"},{"issue":"9 Supplement 1","key":"10.1002\/14651858.CD013006.pub2-BIB0025|cit25","first-page":"132S","article-title":"A double-blind placebo-controlled study of exenatide for the treatment of weight gain associated with olanzapine in overweight or obese adults with bipolar disorder, major depressive disorder, schizophrenia or schizoaffective disorder","volume":"77","author":"Patino","year":"2015","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD013006.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/JCP.0000000000000469","article-title":"Naturalistic randomized placebo-controlled trial of extended-release metformin to prevent weight gain associated with olanzapine in a US community-dwelling population","volume":"36","author":"Rado","year":"2016","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0027|cit27","unstructured":"The effects and safety of topiramate or metformin on obesity induced by antipsychotics in patients with mental disorders: a randomized clinical trial www.who.int\/trialsearch\/Trial2.aspx?TrialID=ChiCTR-IPR-17013122"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0028|cit28","unstructured":"Zonegran for the treatment of weight gain associated with psychotropic medication use: a placebo-controlled trial clinicaltrials.gov\/show\/NCT00203450"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0029|cit29","unstructured":"Lifestyle intervention for diabetes and weight management in psychosis clinicaltrials.gov\/show\/NCT01828931"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0030|cit30","unstructured":"An acceptance-based behavioral intervention vs. nutritional counselling for weight loss in psychotic illness clinicaltrials.gov\/show\/NCT02130596"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0031|cit31","unstructured":"Psychosocial intervention for women with mood disorders seeking treatment for obesity clinicaltrials.gov\/show\/NCT03743844"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013006.pub2-BIB0032|cit32","first-page":"165","article-title":"Management of obesity associated with antipsychotic medication","volume":"8","author":"Wirshing","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S96-S97","DOI":"10.1093\/schbul\/sbz022.021","article-title":"Trial of integrated tobacco smoking cessation, exercise and weight management in persons with serious mental illness","volume":"45","author":"Daumit","year":"2019","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0034|cit34","unstructured":"Metformin for overweight and obese children and adolescents with BDS treated with SGAs (MOBILITY) clinicaltrials.gov\/show\/NCT02515773"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0035|cit35","unstructured":"Lifestyle intervention for young adults with serious mental illness clinicaltrials.gov\/show\/NCT02815813"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0036|cit36","unstructured":"Saxenda\u00ae in obese or overweight patients with stable bipolar disorder clinicaltrials.gov\/show\/NCT03158805"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0037|cit37","unstructured":"Peer navigators to address obesity-related concerns for African Americans with serious mental illness clinicaltrials.gov\/show\/NCT03382782"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0038|cit38","unstructured":"Micronutrients as adjunctive treatment for bipolar disorder clinicaltrials.gov\/show\/NCT03541031"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0039|cit39","unstructured":"Interactive obesity treatment approach (iOTA) for obesity prevention in serious mental illness clinicaltrials.gov\/show\/NCT03695289"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0040|cit40","unstructured":"Interactive obesity treatment approach (iOTA) for obesity prevention in adults with early serious mental illness: iOTA-SMI clinicaltrials.gov\/show\/NCT03980743"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0041|cit41","unstructured":"Effectiveness of a psycho-education program in patients with severe mental disorder clinicaltrials.gov\/show\/NCT04272541"},{"issue":"2","key":"10.1002\/14651858.CD013006.pub2-BIB0042|cit42","first-page":"s5","article-title":"Executive summary: guidelines (2013) for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Obesity Society","volume":"22","author":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","year":"2014","journal-title":"Obesity"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0043|cit43","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0044|cit44","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.HYP.0000165680.59733.d4","article-title":"Effects of weight loss in overweight\/obese individuals and long-term hypertension outcomes: a systematic review","volume":"45","author":"Aucott","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0447.1999.tb10908.x","article-title":"Body weight gain induced by antipsychotic drugs","volume":"100","author":"Baptista","year":"1999","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0047|cit47","volume-title":"Cognitive Therapy of Depression","author":"Beck","year":"1979"},{"issue":"8","key":"10.1002\/14651858.CD013006.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1176\/ps.2010.61.8.774","article-title":"Lifestyle interventions for adults with serious mental illness: a systematic literature review","volume":"61","author":"Cabassa","year":"2010","journal-title":"Psychiatric Services (Washington, D.C.)"},{"issue":"8","key":"10.1002\/14651858.CD013006.pub2-BIB0049|cit49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003641.pub4","article-title":"Surgery for weight loss in adults","author":"Colquitt","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD013006.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0269881116645254","article-title":"BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment","volume":"30","author":"Cooper","year":"2016","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. 1. Prevalence, impact of medications and disparities in health care","volume":"10","author":"DeHert","year":"2011","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12888-016-1049-5","article-title":"Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis","volume":"16","author":"Silva","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0053|cit53","unstructured":"Deeks JJ Higgins JPT on behalf of the Cochrane Statistical Methods Group Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.ajp.160.1.112","article-title":"Obesity as a correlate of outcome in patients with bipolar I disorder","volume":"160","author":"Fagiolini","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD013006.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"675\u2013712","DOI":"10.1016\/S2215-0366(19)30132-4","article-title":"The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness","volume":"6","author":"Firth","year":"2019","journal-title":"The Lancet Psychiatry"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1467-789x.2001.00032.x","article-title":"Obesity and health-related quality of life","volume":"2","author":"Fontaine","year":"2001","journal-title":"Obesity Review"},{"issue":"2","key":"10.1002\/14651858.CD013006.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.14m09300","article-title":"Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort","volume":"76","author":"Goldstein","year":"2014","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0058|cit58","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"issue":"10","key":"10.1002\/14651858.CD013006.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","article-title":"Costs of disorders of the brain in Europe 2010","volume":"21","author":"Gustavsson","year":"2011","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0062|cit62","doi-asserted-by":"crossref","DOI":"10.1093\/med:psych\/9780198528883.001.0001","volume-title":"Cognitive Behavioural Processes Across Psychological Disorders","author":"Harvey","year":"2004"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1192\/bjp.bp.117.202606","article-title":"Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014","volume":"211","author":"Hayes","year":"2017","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013006.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1592\/phco.20.4.270.34882","article-title":"Orlistat, a new lipase inhibitor for the management of obesity","volume":"20","author":"Heck","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0066|cit66","unstructured":"Higgins JPT Deeks JJ Chapter 16. Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0067|cit67","unstructured":"Higgins JPT Altman DG Chapter 8. Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2146\/ajhp100638","article-title":"Lorcaserin: an investigational serotonin 2C agonist for weight loss","volume":"68","author":"Hurren","year":"2011","journal-title":"American Journal of Health Systems Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD013006.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.166.5.654","article-title":"A brief mental health outcome scale - reliability and validity of the Global Assessment of Functioning (GAF)","volume":"166","author":"Jones","year":"1995","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13063-015-0553-0","article-title":"Development of a core outcome set for use in mental health trials involving people with schizophrenia of bipolar disorder in a community based setting","volume":"16","author":"Keeley","year":"2015","journal-title":"Trials"},{"issue":"9","key":"10.1002\/14651858.CD013006.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2146\/ajhp140034","article-title":"Past and present of antiobesity agents: focus on monoamine modulators","volume":"72","author":"Khorassani","year":"2015","journal-title":"American Journal of Health Systems Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD013006.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2165\/00019053-200321090-00001","article-title":"Costs of bipolar disorder","volume":"21","author":"Kleinman","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1002\/14651858.CD013006.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1503\/cmaj.061409","article-title":"2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children","volume":"176","author":"Lau","year":"2007","journal-title":"Canadian Medical Association Journal"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Medicine"},{"issue":"12","key":"10.1002\/14651858.CD013006.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"358","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD013006.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4088\/JCP.v65n0507","article-title":"Are mood disorders and obesity related? A review for the mental health professional","volume":"65","author":"McElroy","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013006.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4088\/JCP.7075su1c.03","article-title":"Obesity in patients with severe mental illness: overview and management","volume":"70","author":"McElroy","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013006.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"273\u201381","DOI":"10.1177\/070674370104600308","article-title":"Antipsychotic metabolic effects: weight gain, diabetes mellitus and lipid abnormalities","volume":"46","author":"McIntyre","year":"2001","journal-title":"Canadian Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013006.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1002\/14651858.CD013006.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD013006.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1399-5618.2010.00865.x","article-title":"Development of the QoL.BD: a disorder-specific scale to assess quality of life in bipolar disorder","volume":"12","author":"Michalak","year":"2010","journal-title":"Bipolar Disorders"},{"issue":"12","key":"10.1002\/14651858.CD013006.pub2-BIB0082|cit82","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006629","article-title":"Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems","author":"Mukundan","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD013006.pub2-BIB0083|cit83","first-page":"579","article-title":"Review of olanzapine in the management of bipolar disorders","volume":"3","author":"Narasimhan","year":"2007","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"4","key":"10.1002\/14651858.CD013006.pub2-BIB0084|cit84","first-page":"8","article-title":"Antipsychotic medications: metabolic and cardiovascular risk","volume":"68","author":"Newcomer","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0085|cit85","unstructured":"National Institute for Health and Care Excellence (NICE) Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children www.nice.org.uk\/nicemedia\/live\/11000\/30365\/30365.pdf"},{"issue":"9555","key":"10.1002\/14651858.CD013006.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"The Lancet"},{"issue":"11","key":"10.1002\/14651858.CD013006.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.metabol.2015.08.001","article-title":"Pharmacotherapy for the management of obesity","volume":"64","author":"Patel","year":"2015","journal-title":"Metabolism"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0088|cit88","unstructured":"Review Manager 5 (RevMan 5) Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"issue":"04","key":"10.1002\/14651858.CD013006.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S135246580001643X","article-title":"What is motivational interviewing?","volume":"23","author":"Rollnick","year":"1995","journal-title":"Behavioural and Cognitive Psychotherapy"},{"issue":"2","key":"10.1002\/14651858.CD013006.pub2-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003818.pub2","article-title":"Psychological interventions for overweight or obesity","author":"Shaw","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD013006.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/0973-1229.58819","article-title":"Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management","volume":"8","author":"Shrivastava","year":"2010","journal-title":"Mens Sana Monographs"},{"issue":"7","key":"10.1002\/14651858.CD013006.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpsyc.63.7.824","article-title":"Association between obesity and psychiatric disorders in the US adult population","volume":"63","author":"Simon","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impression (CGI) scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD013006.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1600-0447.2008.01334.x","article-title":"Which comes first: atypical antipsychotic treatment or cardiometabolic risk?","volume":"119","author":"Stahl","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0095|cit95","unstructured":"Sterne JAC Egger M Moher D Chapter 10. Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"6","key":"10.1002\/14651858.CD013006.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"688\u201393","DOI":"10.1007\/s10597-011-9376-y","article-title":"Cardiovascular risk factors in patients with schizophrenia receiving continuous medical care","volume":"47","author":"Ussher","year":"2011","journal-title":"Community Mental Health Journal"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0097|cit97","volume-title":"SF-36 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"1993"},{"issue":"4","key":"10.1002\/14651858.CD013006.pub2-BIB0098|cit98","first-page":"34","article-title":"Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia","volume":"68","author":"Weiden","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD013006.pub2-BIB0099|cit99","first-page":"153","article-title":"Psychotropic-induced weight gain: a review of management strategies","volume":"53","author":"White","year":"2013","journal-title":"Consultant"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0100|cit100","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders","author":"World Health Organization (WHO)","year":"1992"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0101|cit101","unstructured":"World Health Organization Mental disorders Fact sheet N\u00b0396. www.who.int\/mediacentre\/factsheets\/fs396\/en\/"},{"issue":"7","key":"10.1002\/14651858.CD013006.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1002\/14651858.CD013006.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.2015.1617","article-title":"Naltrexone extended-release plus bupropion extended-release for treatment of obesity","volume":"313","author":"Yanovski","year":"2015","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD013006.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:55:21Z","timestamp":1760972121000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013006.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":104,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013006.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]}}}